RGACX
Price
$75.52
Change
-$0.91 (-1.19%)
Updated
Jun 13 closing price
Net Assets
306.22B
RGEBX
Price
$74.89
Change
-$0.91 (-1.20%)
Updated
Jun 13 closing price
Net Assets
306.22B
Interact to see
Advertisement

RGACX vs RGEBX

Header iconRGACX vs RGEBX Comparison
Open Charts RGACX vs RGEBXBanner chart's image
American Funds Growth Fund of Amer R3
Price$75.52
Change-$0.91 (-1.19%)
VolumeN/A
Net Assets306.22B
American Funds Growth Fund of Amer R2E
Price$74.89
Change-$0.91 (-1.20%)
VolumeN/A
Net Assets306.22B
RGACX vs RGEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RGACX vs. RGEBX commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGACX is a Buy and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGACX (306B) and RGEBX (306B) have equal amount of cash in the bank . RGACX pays higher dividends than RGEBX: RGACX (0.08) vs RGEBX (0.00). RGACX was incepted earlier than RGEBX: RGACX (23 years) vs RGEBX (11 years). RGEBX (1.09) is less costly to investors than RGACX (0.94). RGACX (25.00) and RGEBX (25.00) have comparable annual turnover. RGACX (250) and RGEBX (250) have matching initial minimum investment requirements. RGEBX annual gain was more profitable for investors over the last year : 7.68 vs. RGACX (6.70). RGACX (46.78) and RGEBX (45.42) have equivalent 5 years return.
RGACXRGEBXRGACX / RGEBX
Total Expense Ratio0.941.0986%
Annual Report Gross Expense Ratio0.941.0986%
Fund Existence23 years11 years-
Gain YTD4.9034.829102%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets306B306B100%
Annual Yield % from dividends0.080.00-
Returns for 1 year6.707.6887%
Returns for 3 years51.9051.01102%
Returns for 5 years46.7845.42103%
Returns for 10 years69.6865.87106%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APGE44.482.62
+6.26%
Apogee Therapeutics
VVOS2.140.01
+0.47%
Vivos Therapeutics
SJM95.72-1.65
-1.69%
JM Smucker Company (The)
ELVA3.38-0.17
-4.79%
Electrovaya
NNDM1.44-0.12
-7.69%
Nano Dimension Ltd